G

Glialign

3 employees

Glialign is developing a novel cell therapy for peripheral nerve repair.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care

Date founded

2017

Funding rounds raised

G

Glialign raised undisclosed on May 4, 2018

Investors: UCL Technology Fund, Future Planet Capital, UK Innovation & Science Seed Fund and Innovate UK

FAQ